Role of T-type calcium channel subunits in post-myocardial infarction remodelling probed with genetically engineered mice

被引:19
作者
Le Quang, Khai [1 ,2 ,3 ]
Naud, Patrice [1 ,2 ,3 ]
Qi, Xiao-Yan [1 ,2 ,3 ]
Duval, Francine [1 ,2 ,3 ]
Shi, Yan-Fen [1 ,2 ,3 ]
Gillis, Marc-Antoine [1 ,2 ,3 ]
Comtois, Philippe
Tardif, Jean-Claude [1 ,2 ,3 ]
Li, Danshi [4 ]
Levesque, Paul C. [4 ]
Dobrev, Dobromir [5 ]
Charpentier, Flavien [6 ]
Nattel, Stanley [1 ,2 ,3 ,7 ]
机构
[1] Univ Montreal, Res Ctr, Montreal, PQ H1T 1C8, Canada
[2] Univ Montreal, Dept Med, Montreal, PQ H1T 1C8, Canada
[3] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada
[4] Bristol Myers Squibb Co, Princeton, NJ USA
[5] Univ Heidelberg, Med Fac Mannheim, Div Expt Cardiol, D-6800 Mannheim, Germany
[6] INSERM, Inst Thorax, UMR S915, F-44000 Nantes, France
[7] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada
关键词
Ca-channel; Gene expression; Infarction; Remodelling; CA2+ CHANNELS; VENTRICULAR MYOCYTES; HEART-FAILURE; MIBEFRADIL; RATS; DOGS; EFONIDIPINE; ANTAGONIST; MECHANISMS; EXPRESSION;
D O I
10.1093/cvr/cvr082
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Previous studies suggested that T-type Ca2+-current (I-CaT)-blockers improve cardiac remodelling, but all available I-CaT-blockers have non-specific actions on other currents and/or functions. To clarify the role of I-CaT in cardiac remodelling, we studied mice with either of the principal cardiac I-CaT-subunits (Cav3.1 or Cav3.2) knocked out. Methods and results Adult male Cav3.1- or Cav3.2-knockout (Cav3.1(-/-), Cav3.2(-/-)) mice and respective wild-type (WT) littermate controls were subjected to left anterior descending coronary artery ligation to create myocardial infarction (MI). Echocardiography and programmed electrical stimulation were performed at baseline and 4 weeks post-MI. At baseline, Cav3.1(-/-) mice had slowed heart rates and longer PR intervals vs. WT, but no other electrophysiological and no haemodynamic differences. Cav3.2(-/-) showed no differences vs. WT. Contractile indices (left ventricular fractional shortening and ejection fraction) decreased more post-MI in Cav3.1(-/-) mice than in Cav3.1(+/+) (e. g. by 34 and 29% for WT; 50 and 45% for Cav3.1(-/-), respectively; P < 0.05 for each). Cav3.1(-/-) mice had increased ventricular tachycardia (VT) inducibility post-MI (9 of 11, 82%) vs. WT (3 of 10, 30%; P < 0.05). Cav3.2(-/-) mice were not different in cardiac function or VT inducibility vs. WT. Quantitative polymerase chain reaction showed that Cav3.1 is the major I-CaT-subunit and that no compensatory Cav3.2 up-regulation occurs in Cav3.1(-/-) mice. Cav3.1(-/-) and Cav3.2(-/-) mice had no mRNA expression for the knocked-out gene, at baseline or post-MI. Conclusion Our findings suggest that, contrary to suggestions from previous studies with (imperfectly selective) pharmacological agents having T-type Ca2+-channel-blocking actions, elimination of Cav3.1 expression leads to impaired cardiac function and enhanced arrhythmia vulnerability post-MI, whereas Cav3.2 elimination has no effect.
引用
收藏
页码:420 / 428
页数:9
相关论文
共 30 条
[1]   Comparison of effects of nitrendipine, lacidipine and mibefradil on postischaemic myocardial damage in isolated rat hearts [J].
Arh, M ;
Budihna, MV .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2000, 440 (05) :R149-R150
[2]   The Cav3.2 T-Type Ca2+ Channel Is Required for Pressure Overload-Induced Cardiac Hypertrophy in Mice [J].
Chiang, Chien-Sung ;
Huang, Ching-Hui ;
Chieng, Hockling ;
Chang, Ya-Ting ;
Chang, Dory ;
Chen, Ji-Jr ;
Chen, Yong-Cyuan ;
Chen, Yen-Hui ;
Shin, Hee-Sup ;
Campbell, Kevin P. ;
Chen, Chien-Chang .
CIRCULATION RESEARCH, 2009, 104 (04) :522-U194
[3]  
Chouabe C, 1998, MOL PHARMACOL, V54, P695
[4]   Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling [J].
Cohn, JN ;
Ferrari, R ;
Sharpe, N .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (03) :569-582
[5]   Beneficial effects of the T- and L-type calcium channel antagonist, mibefradil, against exercise-induced myocardial stunning in dogs [J].
de Curzon, OP ;
Ghaleh, B ;
Hittinger, L ;
Giudicelli, JF ;
Berdeaux, A .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 (02) :240-248
[6]   High affinity interaction of mibefradil with voltage-gated calcium and sodium channels [J].
Eller, P ;
Berjukov, S ;
Wanner, S ;
Huber, I ;
Hering, S ;
Knaus, HG ;
Toth, G ;
Kimball, SD ;
Striessnig, J .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (03) :669-677
[7]   T-type Ca2+ channels and pharmacological blockade:: Potential pathophysiological relevance [J].
Ertel, SI ;
Ertel, EA ;
Clozel, JP .
CARDIOVASCULAR DRUGS AND THERAPY, 1997, 11 (06) :723-739
[8]   The T-Type Ca2+ channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs [J].
Fareh, S ;
Bénardeau, A ;
Thibault, B ;
Nattel, S .
CIRCULATION, 1999, 100 (21) :2191-2197
[9]   Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs [J].
Fareh, S ;
Bénardeau, A ;
Nattel, S .
CARDIOVASCULAR RESEARCH, 2001, 49 (04) :762-770
[10]   Ca2+ Influx Through T- and L-Type Ca2+ Channels Have Different Effects on Myocyte Contractility and Induce Unique Cardiac Phenotypes [J].
Jaleel, Naser ;
Nakayama, Hiroyuki ;
Chen, Xiongwen ;
Kubo, Hajime ;
MacDonnell, Scott ;
Zhang, Hongyu ;
Berretta, Remus ;
Robbins, Jeffrey ;
Cribbs, Leanne ;
Molkentin, Jeffery D. ;
Houser, Steven R. .
CIRCULATION RESEARCH, 2008, 103 (10) :1109-U110